Jihun Ahn
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Long-term clinical outcomes of revascularization compared with medical treatment in chronic total occlusion patients with reduced left ventricular ejection fractions.
Journal: Coronary artery disease
Published: August 22, 2025
Prognostic impact of changes in left ventricular ejection fraction and wall motion score index in patients with myocardial infarction.
Journal: Frontiers in cardiovascular medicine
Published: November 18, 2024
Three-Year Clinical Outcomes With the Cilotax Dual Drug-Eluting Stent vs Everolimus-Eluting Stents in Patients With Acute Myocardial Infarction.
Journal: Texas Heart Institute journal
Published: April 30, 2024
Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: July 10, 2023
Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trial.
Journal: American heart journal
Published: March 31, 2023
Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
Journal: American heart journal
Published: August 30, 2022
Effect of systolic dysfunction and elevated left ventricular end diastolic pressure on 3-year clinical outcomes in patients with atrial fibrillation.
Journal: Echocardiography (Mount Kisco, N.Y.)
Published: June 12, 2021
Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients.
Journal: Journal of diabetes and metabolic disorders
Published: November 27, 2019
Last Updated: 09/26/2026